COPD Medication Nonadherence Linked to Faster Lung Function Decline
Medication nonadherence among individuals with chronic obstructive pulmonary disease (COPD) is significantly influenced by affordability and a lack of understanding about medications, leading to increased exacerbations and a more rapid decline in lung function, according to recent research published in January 2026.
Understanding COPD
COPD, encompassing conditions like emphysema and chronic bronchitis, affects over 30 million Americans and stands as the fourth leading cause of death globally COPD Foundation. The disease can stem from genetic predispositions and exposure to irritants such as smoke or pollution American Lung Association.
The Impact of Nonadherence
Inhaled medications play a crucial role in managing COPD symptoms and reducing the frequency of exacerbations. However, studies indicate that approximately 43% to 58.7% of patients do not adhere to their prescribed medication regimens, resulting in higher hospitalization rates and increased mortality.
COPDGene® Study Findings
A study analyzing data from 2,521 participants in the COPD Genetic Epidemiology (COPDGene®) study revealed that 16.2% (408 individuals) reported cost-related nonadherence. This meant they either didn’t fill prescriptions or took less medication than prescribed due to financial constraints or lack of insurance coverage. Notably, 93.5% of those experiencing cost-related nonadherence did have some form of health insurance.
Researchers found that those who couldn’t afford their medications experienced a quicker decline in lung function, more frequent exacerbations, and a greater symptom burden Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation.
Barriers to Medication Adherence
Several factors contribute to medication nonadherence in COPD patients. High out-of-pocket costs for brand-name inhalers are a significant barrier. The Inflation Reduction Act, with its negotiation of drug prices for some medications, may help alleviate this issue.
Individualized Barriers Identified
A separate study involving interviews with 17 participants from a Chicago academic medical center highlighted the individualized nature of adherence challenges. Nearly half of the participants reported not taking medications as prescribed or using inhalers incorrectly. Reasons cited included forgetfulness, physical limitations, a lack of understanding regarding proper inhaler use and timing, difficulty accessing healthcare, stigma, and cost.
The Importance of Patient-Physician Communication
“Medication nonadherence is common, but the reasons behind it are highly individual,” stated Dr. Stephanie L. LaBedz of the University of Illinois Chicago. “Physicians demand to understand the full range of barriers their patients face so they can provide better education and connect them with support to ensure medications are used correctly.”
Looking Ahead
Addressing medication nonadherence in COPD requires a multifaceted approach, including broader policy changes to improve medication affordability and enhanced patient education tailored to individual needs. Open communication between patients and healthcare providers is essential to identify and overcome barriers to optimal COPD management.